Vectivbio Ag

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$55Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
36clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2023 $3,823
2024 $30K
2025 $21K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Transplant Surgery $14K
Transplant Hepatology $13K
Hematology & Oncology $8,250
Pediatric Gastroenterology $6,763
Pediatrics $6,000
Pediatric Hematology-Oncology $5,750

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Kishore Iyer New York, NY Transplant Surgery $14,279.68
Syed-Mohammed Jafri Detroit, MI Transplant Hepatology $12,512.74
Yi Bin Chen Boston, MA Hematology & Oncology $8,250.00
Robert Venick Los Angeles, CA Pediatric Gastroenterology $6,763.10
Andrew Mulberg Camden, NJ Pediatrics $6,000.00
John Levine New York, NY Pediatric Hematology-Oncology $5,750.00
Donald Kirby Cleveland, OH Gastroenterology (Internal Medicine) $765.00
Lawrence Olanoff Kiawah Island, SC $562.50
Neil Hyman Chicago, IL Colon & Rectal Surgery $250.00
Anika Ackerman Morristown, NJ Urology $100.00

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.